Sensei Biotherapeutics grants options for 19,300 shares at $19.79 under 2026 inducement plan

Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc.

SNSE

0.00
  • Sensei Biotherapeutics set June 1, 2026 option awards for three new employees covering 19,300 common shares under its 2026 Inducement Plan.
  • Options carry a USD 19.79 exercise price, matching the stock’s June 1, 2026 close.
  • Vesting starts with 25% on the first anniversary of the employee’s start date, then monthly installments over 36 months, subject to continued service.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sensei Biotherapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606041600BIZWIRE_USPR_____20260604_BW986693) on June 04, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.